Honing Biosciences
Bio-therapeutics company that develops and improves cell-based therapies in particular of cancer and other chronic diseases
Honing Biosciences has raised €2.0M across 1 funding round from 1 investor, most recently a Pre-Seed round in Jul 2020. Based in Paris, France; founded 1909; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€2.0M
€2,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2020-07
latest 2020-07
Funding by year
EUR raised per yearHoning Biosciences — funding by year — interactive chart.
Data table
| Honing Biosciences — funding by year | |
|---|---|
| 2020 | €2.0M |
Signals
High confidenceRaise-next likelihood5
base rate 24% for Pre-Seed
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-07 | Pre-Seed | €2.0M | Elaia Partners | View deal → |
Investors
1Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData